IN BRIEF: Genedrive hails memorandum with Saudi Ministry of Health

Related news

Genedrive PLC - Manchester-based point-of-care pharmacogenetic testing company - Announces that its exclusive distribution partner in Saudi Arabia, iDeal iDea for Medical Equipment Technology, has signed a memorandum of understanding with Saudi Arabia’s Ministry of Health. The MoU scope is to pilot Genedrive’s MT-RNR1 ID Kit for potential national implementation under an initiative called ‘Generations Hear.’ Genedrive Chief Executive Officer Gino Miele says: ‘We are delighted with the signing of this MOU, which builds further on our commercial traction in Saudi Arabia and aligns perfectly to the long-term Saudi health goals. We are grateful to our valued partners at iDeal iDea for their support and look forward to progressing through pilot phase with the goal of implementation at national level.’

Current stock price: 0.67 pence each, up 49% on Tuesday afternoon in London

12-month change: down 70%

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Contract wins

Ways to help you invest your money

Our investment accounts

Put your money to work with our range of investment accounts. Choose from ISAs, pensions, and more.

Need some investment ideas?

Let us give you a hand choosing investments. From managed funds to favourite picks, we’re here to help.

Read our expert tips and insights

Our investment experts share their knowledge on how to keep your money working hard across the markets.